First National Bank of Omaha trimmed its holdings in Stryker Co. (NYSE:SYK) by 3.6% in the first quarter, according to the company in its most recent filing with the SEC. The fund owned 2,675 shares of the medical technology company’s stock after selling 100 shares during the quarter. First National Bank of Omaha’s holdings in Stryker were worth $528,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in SYK. YCG LLC raised its holdings in Stryker by 1.0% during the 1st quarter. YCG LLC now owns 8,559 shares of the medical technology company’s stock valued at $1,691,000 after buying an additional 83 shares during the last quarter. Dearborn Partners LLC raised its holdings in Stryker by 4.3% during the 1st quarter. Dearborn Partners LLC now owns 95,917 shares of the medical technology company’s stock valued at $18,946,000 after buying an additional 3,982 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. raised its holdings in Stryker by 67.6% during the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 3,462 shares of the medical technology company’s stock valued at $684,000 after buying an additional 1,396 shares during the last quarter. Segment Wealth Management LLC raised its holdings in Stryker by 2.6% during the 1st quarter. Segment Wealth Management LLC now owns 21,753 shares of the medical technology company’s stock valued at $4,297,000 after buying an additional 555 shares during the last quarter. Finally, Public Employees Retirement Association of Colorado raised its holdings in Stryker by 4.6% during the 1st quarter. Public Employees Retirement Association of Colorado now owns 62,573 shares of the medical technology company’s stock valued at $12,359,000 after buying an additional 2,726 shares during the last quarter. Hedge funds and other institutional investors own 74.67% of the company’s stock.

Shares of Stryker stock opened at $191.02 on Tuesday. The company has a current ratio of 2.12, a quick ratio of 1.30 and a debt-to-equity ratio of 0.68. The firm has a market cap of $70.80 billion, a price-to-earnings ratio of 26.13, a P/E/G ratio of 2.32 and a beta of 0.84. Stryker Co. has a 12-month low of $144.75 and a 12-month high of $199.85.

Stryker (NYSE:SYK) last issued its quarterly earnings data on Tuesday, April 23rd. The medical technology company reported $1.88 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.84 by $0.04. The business had revenue of $3.52 billion for the quarter, compared to the consensus estimate of $3.51 billion. Stryker had a net margin of 25.38% and a return on equity of 26.72%. The company’s quarterly revenue was up 8.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.68 EPS. On average, analysts forecast that Stryker Co. will post 8.15 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 31st. Shareholders of record on Friday, June 28th will be given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 1.09%. The ex-dividend date of this dividend is Thursday, June 27th. Stryker’s payout ratio is currently 28.45%.

A number of research firms recently commented on SYK. Canaccord Genuity upped their price target on shares of Stryker from $185.00 to $190.00 and gave the company a “buy” rating in a report on Wednesday, January 30th. Zacks Investment Research upgraded shares of Stryker from a “hold” rating to a “buy” rating and set a $199.00 price target for the company in a report on Monday, February 4th. Deutsche Bank upped their price target on shares of Stryker from $181.00 to $208.00 and gave the company a “buy” rating in a report on Wednesday, April 24th. ValuEngine upgraded shares of Stryker from a “hold” rating to a “buy” rating in a report on Friday. Finally, Royal Bank of Canada upped their price target on shares of Stryker from $184.00 to $204.00 and gave the company an “outperform” rating in a report on Monday, March 11th. Six investment analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $196.89.

In other Stryker news, Director Louise Francesconi sold 2,679 shares of the business’s stock in a transaction on Thursday, April 25th. The shares were sold at an average price of $187.25, for a total transaction of $501,642.75. Following the transaction, the director now directly owns 15,598 shares of the company’s stock, valued at approximately $2,920,725.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Chairman Kevin Lobo sold 41,750 shares of the business’s stock in a transaction on Monday, March 25th. The shares were sold at an average price of $194.11, for a total transaction of $8,104,092.50. The disclosure for this sale can be found here. Over the last three months, insiders have sold 132,954 shares of company stock worth $25,193,116. Insiders own 7.20% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “First National Bank of Omaha Sells 100 Shares of Stryker Co. (SYK)” was published by Daily Political and is owned by of Daily Political. If you are viewing this piece on another publication, it was illegally copied and republished in violation of U.S. and international copyright laws. The original version of this piece can be viewed at https://www.dailypolitical.com/2019/05/07/first-national-bank-of-omaha-sells-100-shares-of-stryker-co-syk.html.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.

Featured Story: Special Dividends

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.